gopubmed logo
 
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 19 Aug 2016.

Dopey family member 2

C21orf5, DOPEY2
Top mentioned proteins: iMpact, DYRK1A, CBR3, DSS1, synaptojanin 1
Papers on C21orf5
Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study.
NIA-LOAD/NCRAD Family Study Group et al., Indianapolis, United States. In Curr Alzheimer Res, 2012
Gene-based association analyses confirmed previous findings in the ADNI study (ATXN1, HLA-DPB1, RELN, DOPEY2, GSTT1, CHRFAM7A, ERBB4, NRXN1) and identified a new gene (IMMP2L) that may play a role in AD susceptibility.
Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.
Alzheimer's Disease Neuroimaging Initiative and NIA-LOAD/NCRAD Family Study Group et al., Indianapolis, United States. In Plos One, 2011
Case-control association identified a number of previously reported regions (CHRFAM7A, RELN and DOPEY2) as well as a new gene (HLA-DRA).
A quantitative assessment of gene expression (QAGE) reveals differential overexpression of DOPEY2, a candidate gene for mental retardation, in Down syndrome brain regions.
GeneRIF
Lopes et al., Paris, France. In Int J Dev Neurosci, 2009
Results quantify and statistically analyze, for the first time, DOPEY2 expression variations in different regions of the Down syndrome human fetal brains and to compare them to corresponding normal brains.
New cerebellar phenotypes in YAC transgenic mouse in vivo library of human Down syndrome critical region-1.
GeneRIF
Delabar et al., Paris, France. In Biochem Biophys Res Commun, 2008
We proposed DOPEY2 as potential candidate gene for these cerebellar alterations considering its high expression in the brain.
[Cell-cycle negative regulatory gene ANA is over-expressed in the brain tissues of patients with Down syndrome].
Guo et al., Beijing, China. In Beijing Da Xue Xue Bao, 2006
RESULTS: The expression levels of 6 genes in cortex and cerebellum, including DYRK1A, SYNJ1, PCP4, C21orf5, C21orf2 and C21orf106, were comparable between DS and the control.
C21orf5, a human candidate gene for brain abnormalities and mental retardation in Down syndrome.
GeneRIF
Delabar et al., Paris, France. In Cytogenet Genome Res, 2005
C21orf5 selective expression in the key brain structures for learning and memory suggests that C21orf5 overexpression could participate in mental retardation pathogenesis in Down syndrome patients.
C21orf5, a new member of Dopey family involved in morphogenesis, could participate in neurological alterations and mental retardation in Down syndrome.
GeneRIF
Delabar et al., Paris, France. In Dna Res, 2004
C21orf5, could play a role in brain morphogenesis and, when overexpressed, it could participate in neurological features and mental retardation observed in DS patients.
The differentially expressed C21orf5 gene in the medial temporal-lobe system could play a role in mental retardation in Down syndrome and transgenic mice.
GeneRIF
Rachidi et al., Lille, France. In Biochem Biophys Res Commun, 2003
The differentially expressed C21orf5 gene in the medial temporal-lobe system could play a role in Down syndrome.
C21orf5, a novel human chromosome 21 gene, has a Caenorhabditis elegans ortholog (pad-1) required for embryonic patterning.
Antonarakis et al., Genève, Switzerland. In Genomics, 2000
To contribute to the development of the transcription map of human chromosome 21 (HC21), we isolated a new transcript, C21orf5 (chromosome 21 open reading frame 5), encoding a predicted 2298-amino-acid protein.
share on facebooktweetadd +1mail to friends